Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
63°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Dea
Recent news which mentions Dea
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
October 27, 2022
Tickers
CSA
DEA
Tags
News
RTT
Dr/ Sunil Aggarwal
From
Benzinga
3 Top Dividend Stocks to Buy and Hold in 2023
October 25, 2022
Tickers
ABBV
BEP
BEPC
DEA
Tags
Market News
BEP
BEPC
From
Motley Fool
3 High-Yield Dividend Stocks That Could Be Passive-Income Machines
October 22, 2022
Tickers
DEA
DVN
MPW
Tags
DEA
Recent Press Releases
MPW
From
Motley Fool
DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023
October 17, 2022
Tickers
DEA
Tags
Benzinga
Markets
Cannabis
From
Benzinga
3 Attractive REITs With A Dividend Yield Over 6%
October 13, 2022
Tickers
DEA
REIT
SPG
UHT
Tags
real estate investing
Small Cap
UHT
From
Benzinga
3 Ridiculously Cheap High-Yield Dividend Stocks
October 12, 2022
Tickers
DEA
DOC
STAG
Tags
DEA
Recent Press Releases
STAG
From
Motley Fool
DEA's Beginnings Steeped In Racially Discriminatory Drug Laws, Here's Why
October 05, 2022
Tickers
DEA
Tags
Politics
marijuana federal reform
Markets
From
Benzinga
DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
October 04, 2022
Tickers
DEA
GSK
JNJ
Tags
News
GSK
Small Business
From
Benzinga
DEA's Alarming Fentanyl Seizure, Nevada's Nearly $1B In Sales, Oregon Raids Yield Hefty Fines & More
October 04, 2022
Tickers
DEA
LFLY
Tags
DEA
Fentanyl
Mark Friese
From
Benzinga
DEA Claims Doctors Requesting Psilocybin For Dying Patients Have Commercial Interests
September 29, 2022
Tickers
DEA
Tags
Benzinga
psilocybing for terminally ill
Cannabis
From
Benzinga
Congressional Psychedelics Talks: Comments By Officials In Favor, Including Rep. Blumenauer And AOC
September 22, 2022
Tickers
AOC
DEA
Tags
News
Earl Blumenauer
Legal
From
Benzinga
What 4 Analyst Ratings Have To Say About Easterly Government Props
September 14, 2022
Tickers
DEA
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
3 High-Yield Dividend Stocks to Buy in September Without Any Hesitation
September 03, 2022
Tickers
DEA
EPD
MPW
Tags
DEA
Recent Press Releases
Market News
From
Motley Fool
Fetterman Calls On Biden To Decriminalize Cannabis, But White House Defers To States
August 30, 2022
Tickers
DEA
Tags
federal cannabis decriminalization
DEA
Biden Cannabis
From
Benzinga
These dividend stocks can protect you as the Federal Reserve slows the economy
August 25, 2022
Tickers
AIRC
AKR
AMT
AMZN
Tags
DLR
APLE
CTRE
From
MarketWatch
DEA Psychedelic Drugs Banning Attempt: These Are The Two Hallucinogens Under Discussion
August 23, 2022
Tickers
DEA
Tags
David Heldreth
Panacea Plant Sciences
Emory University
From
Benzinga
Good News For Maridose, DEA Grants A Cannabis Cultivation License For Research
August 19, 2022
Tickers
DEA
Tags
DEA
Maridose
Cannabis Research
From
Benzinga
CNBC's Final Trades: Easterly Government Properties, ExxonMobil, Illinois Tool Works And This Health Care Company
August 18, 2022
Tickers
AMGN
DEA
ITW
XOM
Tags
CNBC
Joseph Terranova
Gilman Hill Asset Management
From
Benzinga
Apple, IBM Are CNBC 'Fast Money' Calls Of The Day
August 17, 2022
Tickers
AAPL
AMGN
DEA
IBM
Tags
Small Cap
IBM
Fast Money
From
Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
Tickers
CYBN
DEA
MDD
Tags
Markets
Doug Drysdale
Market/Moving Exclusives
From
Benzinga
3 Dividend Stocks to Buy Right Now Without Any Hesitation
August 14, 2022
Tickers
BEP
BEPC
DEA
MPW
Tags
BEP
DEA
Recent Press Releases
From
Motley Fool
Senate Marijuana & Psychedelics Reforms: Appropriations Committee Chair Patrick Leahy Marks 12 Bills For FY 2023
August 01, 2022
Tickers
DEA
Tags
Legal
News
Markets
From
Benzinga
3 High-Yield Dividend Stocks to Buy in August
August 01, 2022
Tickers
DEA
EPD
MPW
Tags
DEA
Recent Press Releases
Market News
From
Motley Fool
DEA Reports Uptick In Marijuana-Related Seizures & Arrests: Why Is This Happening? NORML Has An Idea
June 16, 2022
Tickers
DEA
Tags
DEA
Cannabis
Morgan Fox
From
Benzinga
This REIT Is Essentially a Bond With Upside
June 16, 2022
Tickers
DEA
Tags
Market News
DEA
Recent Press Releases
From
Motley Fool
Cannabis Reg. Update: FDA To Review CBD Again, DEA Wins In Hemp Extract Case & More
June 14, 2022
Tickers
DEA
Tags
Regulations
Entrepreneurship
News
From
Benzinga
DEA Stonewalling MMJ's MS & Huntington's Disease Clinical Trials For 3 Years
June 10, 2022
Tickers
DEA
Tags
MMJ BioPharma Labs
MMJ BioPharma Cultivation
DEA
From
Benzinga
Activists Protest The DEA For Psilocybin Access
June 05, 2022
Tickers
DEA
Tags
Psychedelics
DEA
Psilocybin
From
Benzinga
DEA Delays Medical Marijuana Clinical Trials Yet Illicit Market Continues To Thrive
June 01, 2022
Tickers
DEA
Tags
Cannabis
Markets
Market News
From
Benzinga
National Institute On Drug Abuse Seeks New Partner Facilities To Produce Research Cannabis, What Are The Requirements?
May 24, 2022
Tickers
DEA
Tags
Marijuana Moment
DEA
Market News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.